Is HCW Biologics Inc (HCWB) overvalued? · rev $6.7M
HCW Biologics Inc (HCWB) is a biotechnology company listed on US.
This page asks whether HCW Biologics Inc (HCWB) looks expensive on cached numbers — not a short thesis.
Latest reported HCWB revenue for 2026-06-30 was $6.7M. Net income was -$1.7M. Revenue was up 2.3% from 2026-03-31 to 2026-06-30. HCWB currently screens at market cap $14.2M.
HCWB currently screens at market cap $14.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next HCWB 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the HCWB stock page for the full model, not this heading.
Not investment advice.